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ABSTRACT 
 
OBJECTIVE: The objective of this selective evidence based medicine review is to determine 
whether or not “Is radiofrequency energy a safe and effective treatment for reducing symptoms 
of gastroesophageal reflux disease in patients 18 years or older?” 
  
STUDY DESIGN: Review of two double-blind, randomized control trials and one double-blind, 
randomized cross-over study published between 2003 and 2012. All studies were published in 
the English language in peer reviewed journals.   
 
DATE SOURCES: Two randomized control trials and one randomized cross-over study were 
found using PubMed. 
 
OUTCOMES MEASURED: The outcomes measured include changes in GERD symptom scores 
for fourteen symptoms, improvement of GERD symptoms based on a GERD HRQL 
questionnaire, decrease in heartburn based on a 6 point Likert scale, and GERD health related 
quality of life based on a 6 point Likert scale.  
 
RESULTS: Arts et al (2012) demonstrated a significant reduction in GERD symptom scores 
after treatment with radiofrequency energy with a p value of < 0.005. Aziz et al (2010) 
demonstrated a significant reduction in GERD symptoms after treatment with radiofrequency 
energy with a p value of < 0.05. Corley at al (2003) demonstrated a significant decrease in both 
heartburn and GERD health related quality of life after treatment with radiofrequency energy 
with a p value of 0.05 and 0.03, respectively. A noted side effect in two of the studies include 
chest pain.  
 
CONCLUSIONS: Results of the three studies demonstrate that radiofrequency energy is an 
effective treatment for reducing the symptoms of gastroesophageal reflux disease. Two studies 
assessing chest pain following radiofrequency energy demonstrated that the safety of 
radiofrequency energy is inconclusive and requires further investigation.  
 
KEY WORDS: gastroesophageal reflux disease, GERD, radiofrequency energy, Stretta  
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INTRODUCTION 
 
 Gastroesophageal reflux disease, commonly known as GERD, is a chronic condition that 
occurs when the lower esophageal sphincter inappropriately relaxes or is weakened. This defect 
allows stomach contents and acid to flow back into the esophagus.7 The irritation from the acid 
and stomach contents on the esophageal lining is what causes the symptoms of GERD, which 
can greatly impact a person’s quality of life. GERD is a common condition. It is estimated that 
GERD affects 15% to 20% of adults in the United States.4 There are approximately 8.9 million 
ambulatory healthcare visits and 4.7 million hospitalizations due to GERD with an annual health 
care cost of 9.8 million dollars.3,5  
The relaxation or weakening of the lower esophageal sphincter can be caused by 
numerous things such as increased abdominal pressure (obesity, pregnancy), medications 
(calcium channel blockers, antihistamines, sedatives, antidepressants, asthma medications), 
smoking, and hiatal hernias.3 The most common symptoms of GERD include substernal 
heartburn and regurgitation. Other symptoms include chest pain, nausea, vomiting, abdominal 
pain, dysphagia, dental erosions, and a chronic cough.4,7 There are numerous complications of 
GERD including esophagitis, esophageal strictures, respiratory problems, and Barrett’s 
metaplasia.7 Barrett’s metaplasia can progress to esophageal adenocarcinoma, which occurs at a 
yearly development rate of 0.1% to 0.3% per year.4 
GERD is treated with both lifestyle modifications and medications. Lifestyle 
modifications include avoiding foods and beverages that exacerbate heartburn and further 
weaken the lower esophageal sphincter (fried and fatty food, chocolate, peppermint, alcohol, 
coffee, vinegar, tomato sauce, citrus, etc.), avoiding aspirin and NSAIDs, eating smaller portions, 
not eating before bedtime, raising the head of the bed, losing weight, and smoking cessation.6 
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Medications include antacids, H2 receptor antagonists, and proton pump inhibitors. Antacids and 
H2 receptor antagonists are used for mild symptoms of GERD. Proton pump inhibitors are the 
treatment of choice for moderate to severe symptoms of GERD.4,6 Unfortunately, patients with 
GERD may not have a sufficient response to high dose PPI medications.1 These medications can 
cause unbearable side effects and are also expensive, ranging anywhere between $2,000 to 
$3,000 per year.3,9 Using radiofrequency energy, which is called the Stretta procedure, is an 
alternative treatment option for patients with symptoms of GERD. It is conducted via a 
minimally invasive procedure with an endoscope that applies controlled radiofrequency energy 
to the lower esophageal sphincter.1,2,3 It promotes symptom relief and decreases the need of PPI 
medication in patients with GERD by improving the antireflux barrier and augmenting the lower 
esophageal pressure.1,2 
OBJECTIVE 
 
The objective of this selective evidence based medicine review is to determine whether or 
not “Is radiofrequency energy is a safe and effective treatment for reducing symptoms of 
gastroesophageal reflux disease in patients 18 years or older?” 
 
METHODS 
 
 Criteria: This selective evidence based medicine review evaluates two double-blind, 
randomized control trials and one double-blind, cross-over study chosen based on population, 
intervention, comparison group, and outcomes measured. The selected population of interest was 
patients 18 years or older with a diagnosis of GERD. The intervention in these three studies was 
radiofrequency energy delivered to the lower esophageal sphincter and gastroesophageal 
junction. The treatment group receiving radiofrequency energy was compared to a group 
receiving a sham procedure. The outcomes measured in these three studies included a decrease in 
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heartburn, improvement or changes in GERD symptoms after radiofrequency energy, and the 
effect on GERD health related quality of life.  
    Data Sources: The key words “gastroesophageal reflux disease,” “GERD,” “radiofrequency 
energy,” and “Stretta” were searched on PubMed to find articles both relevant to the clinical 
question and ones that included patient oriented outcomes. All articles were published in the 
English language between 2003 and 2012 in peer reviewed journals. The inclusion criteria 
included double-blind studies published after 2000 and exclusion criteria included patients under 
18 years old. The statistics used and reported in this selective evidence based medicine review 
include p-values, numbers needed to harm (NNH), numbers needed to treat (NNT), change in 
mean from baseline, and confidence intervals.  
Table 1 – Demographics & Characteristics of Included Studies 
Study Type # 
Pts 
Age 
(years) 
Inclusion 
criteria 
Exclusion 
criteria 
W/D Interventions 
Arts, 
2012 
(1) 
Double-
blind, 
randomized 
cross-over 
study 
22 47 ± 12 Long standing 
history of 
GERD, 
typical GERD 
symptoms, 
response to 
high dose PPI, 
pathological 
esophageal 
pH 
monitoring 
< 18 y/o, hiatal 
hernia, 
Barrett’s, 
erosive 
esophagitis,  
absent 
peristaltic 
contractions on 
manometry, 
coagulation 
disorders 
Not 
noted 
Radiofrequency 
energy 
delivered 
through four 
needle 
electrodes to the 
region of the 
LES  
Aziz, 
2010 
(2) 
Double-
blind, 
randomized 
control trial 
36 Sham: 
32.0 ± 
8.3 (22 
to 48)  
Tx: 
36.7 ± 
9.5 (24 
to 50) 
> 18 y/o, 
heartburn or 
regurgitation 
> 6 months, 
GERD HRQL 
score >18 
when 
medication 
stopped, 
HRQL score 
of  ≤ 10 on 
Hiatal hernia, 
pregnancy, poor 
surgical 
candidate, 
esophagitis, 
Barrett’s 
metaplasia or 
dysplasia, 
collagen 
vascular 
disease, 
Not 
noted 
Single session 
Stretta 
procedure 
(radiofrequency 
energy)  
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medication, 
normal LES 
relaxation, 
abnormal acid 
exposure, no 
esophagitis 
autoimmune 
disease, severe 
dysphagia, 
previous 
esophageal or 
gastric surgery 
Corley, 
2003 
(3) 
Double-
blind, 
randomized 
control trial  
64 Sham:  
52 ± 15 
Tx:  
45 ± 12 
Heartburn or 
regurgitation, 
responsive to 
daily 
medication, 
>18 y/o, 
abnormal 
esophageal 
acid, normal 
esophageal 
peristalsis, 
normal 
sphincter 
relaxation 
Hiatal hernia, 
erosive 
esophagitis, 
Barrett’s, 
extraesophageal 
manifestations 
of GERD, 
coagulation 
disorders, 
mechanical 
prostheses, 
prominent 
dysphagia, 
unstable 
disorders   
8 Radiofrequency 
energy delivery 
to the GEJ 
 
 
OUTCOMES MEASURED  
 
All of the outcomes measured in this selective evidence medicine based review include 
patient oriented evidence. These outcomes include change in GERD symptom scores, 
improvement of GERD symptoms, improvement in the symptom of heartburn, and effect on 
GERD health related quality of life. The Arts et al double-blind, randomized cross-over trial 
measures changes in GERD symptom scores prior to and three months after the radiofrequency 
energy treatment. Fourteen typical and atypical symptoms (heartburn, food regurgitation, acid 
regurgitation, nausea, vomiting, chest pain, dysphagia, odynophagia, coughing, choking, 
dyspnea, wheezing, hoarseness, and throat ache) were scored by the patient on a scale from zero 
to three. Rating the symptom a three indicated that it interfered with daily activities and rating it 
a zero meant the symptom was not present. All of the symptom scores were added together for a 
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maximum cumulative score of 24. The data was reported as a mean change in baseline with a 
standard deviation.1 
The Aziz et al double-blind, randomized control trial measured improvement of GERD 
symptoms. This was assessed based on a GERD health related quality of life (HRQL) 
questionnaire. The baseline GERD HRQL scores were compared with scores both 6 and 12 
months after radiofrequency energy treatment. The data was reported as a mean change in 
baseline with a standard deviation.2 
The Corley et al double-blind, randomized control trial measured a decrease in the 
symptom of heartburn and GERD health related quality of life for multiple different symptoms. 
Both were measured based via a six point Likert scale ranging from no symptoms to 
incapacitating symptoms. The data was reported as both a mean change in baseline with standard 
deviation and dichotomous data.3 
RESULTS 
 
 This selective evidence based medicine review evaluates radiofrequency energy as a 
treatment for GERD. The results of these studies were presented in both continuous and 
dichotomous data: Arts et al presented continuous data, Aziz et al presented continuous and 
dichotomous data, and Corley et al presented continuous and dichotomous data. All three studies 
were randomized with concealment to randomization. All of the patients, clinicians, and study 
workers were kept blind to which patients were in the treatment group for the duration of the 
study.  
 Arts et al is a double-blind, randomized cross-over study that assesses the efficacy of 
radiofrequency energy applied to the region of the gastroesophageal junction and lower 
esophageal sphincter in adults who are 18 years or older with a long-standing history of GERD. 
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The treatment group was compared to a sham procedure. This study involved twenty-two 
patients divided evenly into two groups of eleven participants. One group was placed in the 
radiofrequency energy group initially and the other group placed in the sham procedure first. To 
qualify as a cross-over study, the participants received the opposite procedure three months after 
the initial procedure. Symptom scores of the participants were evaluated both before and 3 
months after the initial procedure for improvement. The symptom scores were obtained via 
patient reports for fourteen typical and atypical symptoms (all scored on a scale from 0 to 3 for a 
maximum score of 24) and continuous data was reported as mean change from baseline. The 
mean change from baseline for the radiofrequency energy treatment group was 14.7 +/- 1.5 
before the procedure to 8.3 +/- 1.9 at three month follow up. The mean change from baseline for 
the sham procedure group was 16.1 +/- 2.5 before procedure to 15.6 +/- 2.2 at three month 
follow up. At the conclusion of the study, it was determined there was a significant decrease in 
symptom scores of GERD with a statistically significant p-value of < 0.005.1  
Table 2 – GERD Symptom Scores at Baseline and 3 Month Follow Up  
 Baseline  3 Month Follow Up  
Radiofrequency Energy 
Procedure 
14.7 +/- 1.5 8.3 +/- 1.9 
Sham Procedure  16.1 +/- 2.5 15.6 +/- 2.2 
 
 Aziz et al is a double-blind, randomized control trial that assesses the efficacy and safety 
of radiofrequency energy to the gastroesophageal junction in adults who are 18 years or older. 
The treatment group was compared to a sham procedure. Thirty-six participants were placed into 
one of three groups: twelve patients in a single radiofrequency energy procedure group, twelve 
patients in a sham procedure group, and twelve patients in a two-series radiofrequency energy 
group. For the purpose of this selective evidence based medicine review, the single 
radiofrequency energy and the sham groups will be focused on. The study measured 
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improvement of GERD symptoms based on a GERD related health quality of life questionnaire 
at 6 and 12 months after the procedure. Only the twelve month follow up results were presented 
as mean change from baseline. The mean change in baseline for the single radiofrequency energy 
treatment group was 29.6 +/- 3.9 before treatment to 14.7 +/- 4.8 at twelve month follow up. The 
mean change from baseline for the sham group was 30.3 +/- 3.8 before the procedure to 24.8 +/- 
4.9 at twelve month follow up. At the conclusion of the study, it was determined there was a 
significant decrease in GERD symptoms with a statistically significant with a p-value of < 0.05.2 
Table 3 – Improvement of GERD Symptoms at Baseline and 12 Month Follow Up  
 Baseline 12 Month Follow Up  
Single Radiofrequency Energy 
Procedure 
29.6 +/- 3.9 14.7 +/- 4.8 
Sham Procedure  30.3 +/- 3.8 24.8 +/- 4.9 
 
 Corley et al is a double-blind, randomized control trial that assesses efficacy and safety of 
radiofrequency energy to the gastroesophageal junction in adults who are 18 years or older. The 
treatment group was compared to a sham procedure. Sixty-four patients with GERD were 
randomly assigned to a radiofrequency energy group (35 patients) or a sham group (29 patients). 
The study measured a decrease in the symptom of heartburn based on a 6 point Likert scale 
ranging from no symptoms to incapacitating symptoms. The decrease in the symptom of 
heartburn was reported as both continuous and dichotomous data at 6 month follow up. The 
mean change in baseline for patients in the radiofrequency energy group was -1.6 (95% 
confidence interval of -1.1 to -2.2) compared to a mean change in baseline of -0.6 (95% 
confidence interval of 0.1 to -1.2, p = 0.01) in the sham procedure group. At six month follow 
up, 61% of patients in the radiofrequency energy group and 33% of patients in the sham 
procedure group were without heartburn symptoms. This was determined to be statistically 
significant with a p-value value of 0.05.3 The RBI was determined to be 85% and the ABI was 
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determined to be 28%. Numbers needed to treat was determined to be 4. Table 4 displays the 
effectiveness of radiofrequency energy in decreasing the symptom of heartburn for this study. 
Table 4 – Effectiveness of Radiofrequency Energy at Reducing Symptom of Heartburn  
 Sham 
Procedure 
(CER) 
Radiofrequency 
Energy 
Procedure 
(EER) 
Relative 
Benefit 
Increase 
(RBI)  
Absolute 
Benefit 
Increase (ABI)  
Number 
Needed to 
Treat (NNT)  
Corley 
(2003) 
.33 .61 .61-
.33/.33=.85 
.61-.33=.28 1/.28=3.57 = 4  
 
 Corley at al also evaluated improvement of GERD health related quality of life scores for 
multiple symptoms based off of a 6 point Likert scale ranging from no symptoms to 
incapacitating. The improvement of GERD health related quality of life was reported as both 
dichotomous and continuous data at 6 month follow up. The mean change in baseline for patients 
in the radiofrequency energy group was -13 (95% confidence interval of -9 to -17) compared to a 
mean change in baseline of -3 (95% confidence interval of -8 to 2, p = 0.003) in the sham 
procedure group. At six month follow up, 61% of patients in the radiofrequency energy group 
and 30% of patients in the sham procedure group had more than a 50% improvement in their 
GERD health related quality of life score. This was determined to be statistically significant with 
a p-value of 0.03.3 The RBI was determined to be over 100% and the ABI was determined to be 
31%. Numbers needed to treat was determined to be 4. Table 5 displays the effectiveness of 
radiofrequency energy in improving GERD health related quality of life scores. 
Table 5 – Effectiveness of Radiofrequency Energy on GERD Health Related Quality of Life  
 Sham 
Procedure 
(CER) 
Radiofrequency 
Energy 
Procedure 
(EER) 
Relative 
Benefit 
Increase 
(RBI)  
Absolute 
Benefit 
Increase (ABI)  
Number 
Needed to 
Treat (NNT)  
Corley 
(2003) 
.30 .61 .61-
.30/.30=1.03 
.61-.30=.31 1/.31=3.22 = 4  
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For this selective evidence based medicine review, the common side effect of chest pain 
was evaluated. Aziz et al and Corley et al evaluated chest pain after treatment with single 
radiofrequency energy or sham procedure. Aziz et al determined that 58% of patients had chest 
pain following radiofrequency energy procedure and 16.6% of patients had chest pain following 
sham procedure.2 Corley et al determined that 11% of patients had chest pain following 
radiofrequency energy procedure and 0% of patients had chest pain following sham procedure.3 
Table 6 indicates the number of patients who had chest pain after receiving treatment with either 
the radiofrequency energy or the sham procedure.  
Table 6 –  Safety of Radiofrequency Energy from Selected Studies: NNH 
Study  Patients 
with Chest 
Pain 
following 
Sham 
Procedure 
(CER) 
Patients with 
Chest Pain 
following 
Radiofrequency 
Energy 
Procedure 
(EER) 
Relative Risk 
Increase (RRI) 
Absolute Risk 
Increase 
(ARI) 
Numbers 
Needed to 
Harm (NNH) 
Aziz 
(2010)  
.166  .58 .58-.166/.58 = .71 .58-.166 = .41 1/.41 = 2.43 = 
3   
Corley 
(2003) 
0 .11 .11-0/.11 = 1 .11 – 0 = .11 1/.11 = 9.09 = 
10 
 
DISCUSSION  
  
The radiofrequency energy procedure that is offered in the United States is called the 
Stretta system. This system was approved by the Food and Drug Administration in 2000.9 
According to Vanderbilt University Medical Center, this endoscopic procedure may cost 
anywhere from $7,500 to $10,000.9 Unfortunately, there is no frank answer as to whether 
insurance will cover the Stretta procedure. However, Aetna determined that the Stretta procedure 
was experimental and investigational based on a review of the current clinical information. Aetna 
also states that the patient’s medical claim determines whether or not a particular medical 
procedure is covered.10 
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The Stretta System is specifically used to coagulate tissue in the region of the lower 
esophageal sphincter and gastroesophageal junction for the treatment of gastroesophageal reflux 
disease.8 Contraindications to the Stretta System include patients younger than 18 years old, 
pregnancy, patients that do not have GERD, patients with a hiatal hernia larger than 2 
centimeters, patients with achalasia, patients who have incomplete lower esophageal sphincter 
relaxation after swallowing, and patients who are poor surgical candidates.8 The Stretta System 
has not been studied in patients who have an implant that might be conductive with the 
radiofrequency energy near the lower esophageal sphincter, patients with a normal twenty-four 
hour pH study, patients with GERD symptoms that are unresponsive to proper anti-secretory 
medication, Barrett’s metaplasia, active esophagitis that is grade three or four by Savary-Miller 
criteria, patients who have risk factors for endocarditis, patients with esophageal bleeding or 
dysphagia, patients who have untreated or unstable hypertension, diabetes mellitus, heart disease, 
or collagen vascular disease, patients on steroids, patients who are immunosuppressed, patients 
with a cardiac pacemaker, and patients who have coagulation abnormalities or are on 
anticoagulation therapy.8 There are complications that may occur with radiofrequency energy 
when treating GERD including bleeding, bloating, chest pain, difficulty belching, dysphagia, 
epigastric pain, laceration of the esophageal mucosa, fever, perforation, pharyngitis, vomiting, 
achalasia, prolonged gastric emptying, dental injury, dyspnea, infection, injury to the larynx, and 
worsening of GERD.8 
All three studies included in this selective evidence based medicine review demonstrated 
limitations. Sample size was the main limitation. Arts et al had a sample size of twenty-two, Aziz 
et al had a sample size of thirty-six, and Corley et al had a sample size of sixty-four.1,2,3 Corley 
et al also had a considerable difference in the number of patients in the treatment group (35 
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patients) and the number of patients in the sham group (29 patients).3 Another limitation was a 
moderate dropout rate. For instance, Corley et al began their study with sixty-four patients and 
ended with fifty-six.3  
CONCLUSIONS  
 
 All three studies successfully demonstrated that there is a significant decrease in 
symptoms of gastroesophageal reflux disease following treatment with radiofrequency energy. 
Therefore, radiofrequency energy is an effective alternative treatment for reducing the symptoms 
of GERD in patients who are 18 years or older. However, the two studies that assessed chest pain 
following radiofrequency energy yielded inconclusive results. Due to this inconsistency, further 
studies are warranted to assess the potential side effect of chest pain following treatment with 
radiofrequency energy. It is also important to follow these patients for a longer period of time in 
order to assess whether or not symptoms of GERD will return or if radiofrequency energy could 
potentially be curative for patients with GERD. Since these three studies compared 
radiofrequency energy to a sham procedure, it would be important to create a study comparing 
radiofrequency energy to another treatment modality, such as long term proton pump inhibitors 
or a surgical anti-reflux procedure, to see which method of treatment would be superior for 
treating symptoms of GERD.  
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